|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-7-25
|
|
pubmed:abstractText |
Tumor hypoxia can influence response to radiotherapy and other treatment modalities. Oxygenation status is proved to be an independent prognostic factor. 99mTc-HL91 (99mTc labeled 4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime) is a potential noninvasive marker of tumor hypoxia. It has been reported that 99mTc-HL91 has certain validity for hypoxia imaging. But its clinical study had not been reported widely. This study was carried out to evaluate the relationship between the T/N ratio of HL91 SPECT hypoxia imaging and the radiotherapeutic outcome.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0253-3766
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
127-30
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17645850-Adult,
pubmed-meshheading:17645850-Aged,
pubmed-meshheading:17645850-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17645850-Cell Hypoxia,
pubmed-meshheading:17645850-Female,
pubmed-meshheading:17645850-Follow-Up Studies,
pubmed-meshheading:17645850-Humans,
pubmed-meshheading:17645850-Kaplan-Meier Estimate,
pubmed-meshheading:17645850-Lung,
pubmed-meshheading:17645850-Lung Neoplasms,
pubmed-meshheading:17645850-Male,
pubmed-meshheading:17645850-Middle Aged,
pubmed-meshheading:17645850-Neoplasm Staging,
pubmed-meshheading:17645850-Organotechnetium Compounds,
pubmed-meshheading:17645850-Oximes,
pubmed-meshheading:17645850-Particle Accelerators,
pubmed-meshheading:17645850-Prognosis,
pubmed-meshheading:17645850-Radiotherapy, Conformal,
pubmed-meshheading:17645850-Remission Induction,
pubmed-meshheading:17645850-Tomography, Emission-Computed, Single-Photon
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
[Prognostic value of 9mTc-HL91 SPECT hypoxia imaging in patients with advanced NSCLC].
|
|
pubmed:affiliation |
Second Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan 250117, China. jn7984729@public.jn.sd.cn
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
